Filing Flows › 908 Devices (MASS) › Q2 2026 › vs Q1 2026
908 Devices (MASS) Q2 2026 vs Q1 2026 (quarter over quarter)
908 Devices's revenue rose $2.7M (+20%) from $13.4M in Q1 2026 to $16.1M in Q2 2026.
908 Devices, Q2 2026: revenue $16.1M (+23% year over year), operating margin -79.7%, net loss $11.9M, operating cash flow $3.2M. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Free cash flow margin | 18.7% | 8.7% | +10.0 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $16.1M | $13.4M | $2.7M | +20% |
| Other income, net | $861K | $929K | −$68K | -7% |
| Income tax benefit | $54K | $0 | $54K | — |
| Net loss | $11.9M | $12.0M | −$61K | -0.5% |
| Costs & expenses | $28.9M | $26.3M | $2.6M | +10% |
| Operating costs | $28.9M | $26.3M | $2.6M | +10% |
| Cost of revenue | $7.7M | $6.5M | $1.2M | +19% |
| Research & development | $3.6M | $3.5M | $127K | +4% |
| SG&A | $11.1M | $9.9M | $1.2M | +12% |
| Other operating costs | $6.4M | $6.4M | $61K | +1% |
| Operating cash sources | $15.1M | $13.2M | $1.9M | +14% |
| Depreciation & amortization | $1.4M | $1.1M | $222K | +19% |
| Share-based compensation | $2.3M | $2.4M | −$86K | -4% |
| Working capital & other | $11.4M | $9.6M | $1.8M | +18% |
| Net loss absorbed | $11.9M | $12.0M | −$61K | -0.5% |
| Operating cash flow | $3.2M | $1.2M | $2.0M | +163% |
| Free cash flow (OCF − capex) | $3.0M | $1.2M | $1.8M | +158% |
| Capital expenditures | $162K | $40K | $122K | +305% |
Questions
How much did 908 Devices's revenue grow quarter over quarter in Q2 2026?
908 Devices's revenue rose $2.7M (+20%) from $13.4M in Q1 2026 to $16.1M in Q2 2026.